{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:23:15Z","timestamp":1790047395801,"version":"4.0.1"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Most breast cancers in Africa are diagnosed at advanced stages. Improved risk prediction tools to optimize screening and earlier diagnosis are urgently needed.<\/jats:p><\/jats:sec>Objective<\/jats:title>To build a comprehensive breast cancer risk estimation model by integrating a polygenic risk score (PRS), pathogenic variants (PVs) in high- or moderate-penetrance genes, and a questionnaire-based risk calculator.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This multicenter case-control study initially enrolled women in Nigeria in 1998 and expanded to Cameroon and Uganda in 2011; enrollment ended in 2018. Women with breast cancer (hereafter cases) were enrolled through hospital oncology units, whereas women without breast cancer (hereafter controls) were recruited from other outpatient clinics and the community. Participants whose genetic data were used in PRS development were excluded from the development of the comprehensive breast cancer risk estimation model. Analyses were performed from September 2023 to January 2025.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Lifetime absolute risk estimation models that integrated a PRS only (previously developed using data from women of African ancestry and European ancestry), PRS plus PVs in high- or moderate-penetrance genes (BRCA1<\/jats:italic>, BRCA2<\/jats:italic>, PALB2<\/jats:italic>, ATM<\/jats:italic>, CHEK2<\/jats:italic>, TP53<\/jats:italic>, BARD1<\/jats:italic>, RAD51C<\/jats:italic>, and RAD51D<\/jats:italic>), epidemiologic risk factors only (ascertained from NBCS questionnaires), and a combined model containing these 3 components.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Lifetime absolute risk of breast cancer was estimated, accounting for an association between family history and genetic factors. Participants\u2019 lifetime estimated absolute risk was categorized by the following risk thresholds: lower than 3%, 3%, 5%, and 10% or higher.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 1686 women, of whom 996 were cases (mean [SD] age at enrollment, 49.5 [12.2] years) and 690 were controls (mean [SD] age at enrollment, 41.5 [13.8] years), were included in the main analyses. The age-adjusted area under the receiver operating characteristic curve (AUROC) was 0.579 (95% CI, 0.549-0.610) for the PRS only model and 0.609 (95% CI, 0.579-0.638) for the PRS plus PV model. In the combined model containing both genetic and nongenetic risk factors, age-adjusted AUROC increased to 0.723 (95% CI, 0.698-0.748). Using a threshold of 10% or higher lifetime absolute risk, the combined model classified 12.0% of cases (120) as high risk compared with 3.7% of cases (37) using the epidemiologic factors only model and 5.0% of cases (50) using the PRS plus PV model.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this case-control study, a breast cancer risk estimation model was developed that combines genetic and nongenetic factors and refines a previous model that includes epidemiologic risk factors. Further development and validation of this model are necessary to advance breast cancer risk assessment in sub-Saharan Africa.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.5804","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T15:30:43Z","timestamp":1744990243000},"page":"e255804","source":"Crossref","is-referenced-by-count":9,"title":["Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation"],"prefix":"10.1001","volume":"8","author":[{"given":"Wenji","family":"Guo","sequence":"first","affiliation":[{"name":"Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"McClellan","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atara","family":"Ntekim","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, College of Medicine, University of Ibadan, Ibadan, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladosu","family":"Ojengbede","sequence":"additional","affiliation":[{"name":"Center for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temidayo","family":"Ogundiran","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi","family":"Odetunde","sequence":"additional","affiliation":[{"name":"Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Obafunwa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiodun","family":"Popoola","sequence":"additional","affiliation":[{"name":"Department of Radiation and Clinical Oncology, Lagos State University Teaching Hospital, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ndom","sequence":"additional","affiliation":[{"name":"Yaounde General Hospital, Yaounde, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Gakwaya","sequence":"additional","affiliation":[{"name":"Department of Surgery, King Ceasor University, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjan","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Sveen","sequence":"additional","affiliation":[{"name":"Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio F.","family":"Yoshimatsu","sequence":"additional","affiliation":[{"name":"Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunmilayo I.","family":"Olopade","sequence":"additional","affiliation":[{"name":"Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois"},{"name":"Center for Global Health, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezheng","family":"Huo","sequence":"additional","affiliation":[{"name":"Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois"},{"name":"Department of Public Health Sciences, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"issue":"3","key":"zoi250239r1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"zoi250239r2","doi-asserted-by":"publisher","first-page":"e923","DOI":"10.1016\/S2214-109X(16)30259-5","article-title":"Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis.","volume":"4","author":"Jedy-Agba","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"10439","key":"zoi250239r3","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(24)00747-5","article-title":"The Lancet Breast Cancer Commission.","volume":"403","author":"Coles","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"zoi250239r4","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1136\/jmg-2022-108806","article-title":"Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study.","volume":"59","author":"Yang","year":"2022","journal-title":"J Med Genet"},{"issue":"6","key":"zoi250239r5","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/ije\/dyab036","article-title":"Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.","volume":"50","author":"Hurson","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"13","key":"zoi250239r6","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1200\/JCO.23.00295","article-title":"Comprehensive inherited risk estimation for risk-based breast cancer screening in women.","volume":"42","author":"Mars","year":"2024","journal-title":"J Clin Oncol"},{"issue":"6","key":"zoi250239r7","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1158\/1055-9965.EPI-17-1128","article-title":"Development of a breast cancer risk prediction model for women in Nigeria.","volume":"27","author":"Wang","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"28","key":"zoi250239r8","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1200\/JCO.2018.78.3977","article-title":"Inherited breast cancer in Nigerian women.","volume":"36","author":"Zheng","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi250239r9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1158\/1055-9965.EPI-19-0506","article-title":"Prevalence of inherited mutations in breast cancer predisposition genes among women in Uganda and Cameroon.","volume":"29","author":"Adedokun","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"zoi250239r10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1158\/1055-9965.EPI-21-1397","article-title":"Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations.","volume":"31","author":"Ahearn","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"zoi250239r11","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/jnci\/djab050","article-title":"Evaluating polygenic risk scores for breast cancer in women of African ancestry.","volume":"113","author":"Du","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"zoi250239r12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10549-017-4638-1","article-title":"Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry.","volume":"168","author":"Wang","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"zoi250239r13","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.08.010419","article-title":"Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis.","volume":"8","author":"Adeloye","year":"2018","journal-title":"J Glob Health"},{"issue":"5","key":"zoi250239r14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/sj.bjc.6604275","article-title":"Parity and breastfeeding are protective against breast cancer in Nigerian women.","volume":"98","author":"Huo","year":"2008","journal-title":"Br J Cancer"},{"issue":"1","key":"zoi250239r15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1158\/1055-9965.EPI-22-0869","article-title":"Validation of the Nigerian Breast Cancer Study model for predicting individual breast cancer risk in Cameroon and Uganda.","volume":"32","author":"Ashi","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"zoi250239r16","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1038\/s41467-018-06616-0","article-title":"Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.","volume":"9","author":"Pitt","year":"2018","journal-title":"Nat Commun"},{"issue":"18","key":"zoi250239r17","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1093\/hmg\/ddac102","article-title":"Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach.","volume":"31","author":"Gao","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"1","key":"zoi250239r18","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/s41467-021-24327-x","article-title":"Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.","volume":"12","author":"Adedokun","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"zoi250239r19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41588-024-01736-4","article-title":"Genome-wide association analyses of breast cancer in women of African ancestry identify new susceptibility loci and improve risk prediction.","volume":"56","author":"Jia","year":"2024","journal-title":"Nat Genet"},{"issue":"1","key":"zoi250239r20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic risk scores for prediction of breast cancer and breast cancer subtypes.","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"2","key":"zoi250239r21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228198","article-title":"iCARE: an R package to build, validate and apply absolute risk models.","volume":"15","author":"Pal Choudhury","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"zoi250239r22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer.","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi250239r23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes: association analysis in more than 113,000 women.","volume":"384","author":"Dorling","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi250239r25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"2","key":"zoi250239r26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/biomet\/asp002","article-title":"Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve.","volume":"96","author":"Janes","year":"2009","journal-title":"Biometrika"},{"issue":"1","key":"zoi250239r27","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1038\/s41467-020-19966-5","article-title":"The role of polygenic risk and susceptibility genes in breast cancer over the course of life.","volume":"11","author":"Mars","year":"2020","journal-title":"Nat Commun"},{"issue":"23","key":"zoi250239r28","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1200\/JCO.20.01992","article-title":"Risk of breast cancer among carriers of pathogenic variants in breast cancer predisposition genes varies by polygenic risk score.","volume":"39","author":"Gao","year":"2021","journal-title":"J Clin Oncol"},{"issue":"7","key":"zoi250239r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.8501","article-title":"Association of a polygenic risk score with breast cancer among women carriers of high- and moderate-risk breast cancer genes.","volume":"3","author":"Gallagher","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi250239r30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41588-020-0609-2","article-title":"Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.","volume":"52","author":"Zhang","year":"2020","journal-title":"Nat Genet"},{"issue":"9","key":"zoi250239r31","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00140","article-title":"Cancer genetic services in a low- to middle-income country: cross-sectional survey assessing willingness to undergo and pay for germline genetic testing.","volume":"9","author":"Adejumo","year":"2023","journal-title":"JCO Glob Oncol"},{"key":"zoi250239r32","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3332\/ecancer.2023.1588","article-title":"Feasibility of cancer genetic counselling and screening in Cameroon: perceived benefits and barriers.","volume":"17","author":"Mapoko","year":"2023","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"zoi250239r33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41525-019-0111-x","article-title":"Evaluating the promise of inclusion of African ancestry populations in genomics.","volume":"5","author":"Bentley","year":"2020","journal-title":"NPJ Genom Med"},{"key":"zoi250239r24","unstructured":"Parkin? DM, Ferlay? J, Jemal? A, , eds. Cancer in Sub-Saharan Africa. IARC Scientific Publication No. 167. IARC; 2018. Accessed January 25, 2025. https:\/\/publications.iarc.fr\/572"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2832972\/guo_2025_oi_250239_1748879963.61744.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T15:00:12Z","timestamp":1749222012000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2832972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.5804","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}